49 episodes

A national multidisciplinary masterclass exploring inflammatory skin and joint related conditions led by healthcare experts from across Canada and the US.

Skin and Joints Podcast Mimi Tran, Aaron Sihota, Danny Mansour, Ashley Yip, Julia Tan, Touraj Khosravi, Anastasiya Muntyanu

    • Health & Fitness

A national multidisciplinary masterclass exploring inflammatory skin and joint related conditions led by healthcare experts from across Canada and the US.

    PART 2: My CasMO Playbook Managing Skin Toxicities in Oncology Treatment with Dr.Maxwell Sauder

    PART 2: My CasMO Playbook Managing Skin Toxicities in Oncology Treatment with Dr.Maxwell Sauder

    🎙️ My CASMO (Canadian Skin Management in Oncology) Playbook: Part 2🎙️

    Description:

    In Part 2, dermooncologist Dr. Max Sauder returns to delve deeper into the CASMO algorithm. We navigate the complexities of managing severe cutaneous reactions in patients undergoing radiation. From identifying critical symptoms that necessitate urgent care to understanding the nuances of radiation dermatitis stages and risk factors, this episode is packed with expert insights and practical advice. We focus on 2 specific areas:

    Assessment and Severity Evaluation: Guidance on evaluating the severity of skin toxicities, incorporating case studies to illustrate practical approaches.
    Management Protocols: Exploration of practical management strategies and specific interventions for common skin toxicities, drawing on literature evidence and expert consensus.

    Learning Objectives:

    Identify Critical Symptoms:

    Recognize severe cutaneous adverse reactions and understand when urgent care is necessary based on symptoms like fever, skin pain, blisters, mucous membrane involvement, and abnormal labs. 🚨

    Understand Radiation Dermatitis:

    Differentiate between acute and chronic radiation dermatitis.
    Learn the grading systems (CTCAE and RTOG) and their simplified applications in the CASMO algorithm. 📊

    How to Manage Radiation Dermatitis:

    Implement effective treatment strategies for both dry and moist desquamation.
    Understand the role of topical steroids and topical over-the-counter dos and don’ts💊

    Recognize Risk Factors:

    Identify the factors that increase the risk of radiation dermatitis, considering the cancer type, radiation modality, and regimen. 🧬
    Learn to manage photosensitivity reactions, particularly with targeted therapies.
    Explore strategies to ensure patient adherence to prescribed skincare and sun protection protocols, emphasizing the importance of these measures in minimizing treatment interruptions. 🛡️

    Photosensitivity Reactions:

    Understand the importance of proactive sun protection and the role of topical treatments. ☀️

    Promote Adherence:

    Explore strategies to ensure patient adherence to prescribed skincare and sun protection protocols, emphasizing the importance of these measures in minimizing treatment interruptions. 🛡️

    Episode Highlights:

    Danger Zone: Learn to identify those serious skin reactions that need urgent care, stat! 🌡️
    Radiation Dermatitis Deep Dive: Understand the stages and treatment of radiation dermatitis without getting lost in the weeds. 📋
    Risk Factors Unmasked: Get to know the usual suspects behind radiation dermatitis. 🔬
    Photosensitivity Savvy: Protect patients from those sneaky photosensitivity reactions with top-notch tips. 🌞
    Adherence Hacks: Keep patients sticking to their skincare and sun protection routines like glue. 🔄

    Join us for a discussion perfect for a quick listen on your commute or work out🎧



    REFERENCES AND FURTHER RESOURCES:

    1.       The role of skin care in oncology patients: STL-Supp-SkinCareOnc-v2-correction.pdf (skintherapyletter.com)

    2.       Canadian general algorithm (cleanse, moisturize, protect):Canadian Skin Management in Oncology (CaSMO) Algorithm for Patients with Oncology Treatment-Related Skin Toxicities (skintherapyletter.com)

    3.       Canadian radiotherapy algorithm:Canadian Skin Management in Oncology Group (Casmo) Algorithm for the Prevention and Management of Acute Radiation Dermatitis (skintherapyletter.com)

    4.       Canadian immunotherapy algorithm: CaSMO Management of Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: A Practical Primer (skintherapyletter.com)

    5.       Canadian hormonal therapy algorithm: Casmo Algorithm for Management of Hormonal Therapy-Related Cutaneous Adverse Effects in Oncology Patients (skintherapyletter.com)

    6.       Canadian targeted therapy algorithm:Casmo Prevention and Management of Four

    • 24 min
    PART 1: My CasMO Playbook Managing Skin Toxicities in Oncology Treatment with Dr.Maxwell Sauder

    PART 1: My CasMO Playbook Managing Skin Toxicities in Oncology Treatment with Dr.Maxwell Sauder

    🌞🎧Dermatologist Dr.Max Sauder joins us back on the podcast and navigates us through the complexities of modern dermatological care💡

    🎙️ My CASMO (Canadian Skin Management in Oncology) Playbook: Part 1 🎙️

    Get ready for a laugh and learn session as Dr. Jessica Asgarpour takes the co-hosting hot seat! This episode, we’re diving headfirst into the CASMO project with dermo-oncologist Dr. Max Sauder. We’ll decode the CASMO algorithm, tackle the nitty-gritty of managing skin toxicities, and even uncover Dr. Sauder's secret summer plans. Buckle up! 🎢

    Episode Description:

    We're peeling back the layers of the CASMO project, an innovative approach to managing skin toxicities in cancer treatment.

    Can certain skin toxicities be prevented in patients? Is there a proactive skincare regimen that can be recommended for patients?
    1. Introduction to CaSMO and Skin Toxicities in Cancer Treatment: Overview of the significance of managing skin toxicities, introducing the CaSMO algorithm's development and objectives.
    2. Prevention Strategies: Detailed discussion on general skincare measures recommended by CaSMO, including the rationale behind the use of cleansers and moisturizers to maintain skin hydration and integrity.

    Episode Learning Objectives:

    1. Understand the CASMO algorithm and its role in managing skin toxicities associated with cancer treatments.
    2. Recognize the importance of a multidisciplinary approach in improving patient outcomes.
    3. Identify practical proactive strategies for preventing and managing skin toxicities.
    4. Learn about the impact of skin toxicities on patients' quality of life and how to address these issues.
    5. Explore the role of various healthcare providers, including oncologists, nurses, and pharmacists, in supporting patients through their cancer journey.

    Press play for a dose of dermatological delight 🎙️✨



    Episode supported by an IME Grant from LA ROCHE POSAY



    About Dr.Maxwell Sauder MD, FRCPC

    Dermatologist  | Toronto

    Dr. Maxwell Sauder is a board-certified dermatologist with additional fellowship training. He earned his Doctor of Medicine at McMaster University and completed a residency in dermatology at The University of Ottawa. He completed fellowship training in Cutaneous Oncology at Harvard Medical School. He is a former instructor in dermatology at Harvard Medical School.

    Dr. Sauder is currently an assistant professor at the University of Toronto. He is an onco-dermatologist at Princess Margaret Cancer Centre. He also practices at Toronto Dermatology Centre where he is the research director and the director of the Pigmented Lesion Clinic.

    Well published in numerous peer-reviewed journals, Dr. Sauder has also authored several book chapters, been referenced on www.uptodate.com, and has won numerous awards including the Partner’s President Prize at Harvard and the Royal College’s Detweiler Fellowship Award. His publications have covered topics such as eczema, patient education, aesthetic dermatology, sun safety, psoriasis, biologics, adverse drug reactions, hemangiomas, contact dermatitis, cutaneous oncology, and a host of complex medical dermatology conditions.



    📻www.skinandjoints.ca

    ✉️info@skinandjoints.ca

    • 23 min
    AAD 2024 LATEBREAKER: Delgocitinib for Long-Term Use in Chronic Hand Eczema

    AAD 2024 LATEBREAKER: Delgocitinib for Long-Term Use in Chronic Hand Eczema

    🎙️ Melinda Knows Best at the AAD! 🌟

    We’ve got a special LATEBREAKER episode for you, continuing our coverage from the American Academy of Dermatology in San Diego!

    👟💡 Pro Tip: Don't miss Dr. Gooderham’s advice on navigating massive convention centers in style and comfort!

    ->We dive into the highly anticipated Delta 3 study, shedding light on long-term safety and efficacy of Delgocitinib cream for Chronic Hand Eczema.

    ---->Subjects who completed the 16-week treatment period in one of the parent trials DELTA 1 and DELTA 2 were treated with twice daily delgocitinib cream as needed to control their chronic hand eczema for 36 weeks.

    ->Practical Tips for Dermatology Practices 🏥💼
    Adapting treatment plans for chronic hand eczema.
    Benefits of as-needed treatment approaches for better patient outcomes.

    ->Dr. Gooderham’s Conference Adventures 🛫👩‍⚕️👨‍⚕️
    Dr. Gooderham also shares her intriguing encounters from Toronto to San Diego, including a surprise meeting with April Armstrong and an old friend from med school. 🛫

    Episode Learning Objectives:
    Understand the primary and secondary endpoints of the Delta 3 study and its implications for treating chronic hand eczema.
    Learn about the safety profile of Delgocitinib cream and its significance in long-term treatment plans.
    Gain insights into real-world application of delgocitinib and patient adherence strategies for topical treatments

    Lace up those sneakers, grab a protein bar, and join us for a walk through the latest dermatological advancements! 🥾🍫
    🎙️ Melinda Knows Best at the AAD – where expert insights meet real-world application (pun intended)📍📍

    Episode supported by an IME Grant from LEO Pharma



    ABOUT Dr.Melinda Gooderham, MD, FRCPC ( Dermatology)

    Dermatologist  | Toronto

    Toronto, ON

    Melinda Gooderham MD MSc FRCPC Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.

    Dr. Gooderham has been the principal investigator for over 200 clinical trials and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 205 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.



    References

    Gooderham M. Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA 3 trial. Presented at: 2024 American Academy of Dermatology Annual Meeting; March 8-12, 2024; San Diego, CA.

    • 19 min
    AAD 2024 Mini Podcast: Alopecia Areata with Dr.Diana Diao

    AAD 2024 Mini Podcast: Alopecia Areata with Dr.Diana Diao

    🎙️🌞 Tight Spaces & Hair-Raising Breakthroughs – Live from AAD San Diego! 🎙️🌴

    Join Skin and Joints Podcast AAD Guest Faculty and Vancouver based dermatologist, Dr,Diana Diao, as she navigates the cramped quarters of a historic boutique hotel in the Gaslamp Quarter—tiny rooms, weird noises, and all! 🏨😅

    Dr. Diao explore groundbreaking sessions on alopecia areata, revealing innovative treatments and valuable clinical insights that are shaping the future of dermatology.

    🌟💊Don't miss out on Dr. Diao's top clinical takeaways that could revolutionize treatment approaches for dermatologists everywhere. Whether it's systemic therapies for extensive scalp involvement or tailored treatments for unique patient profiles, this episode is packed with insights that promise to enhance patient care.

    💬 Tune in, transform your approach with pearls that could change your practice overnight!

    🎧✨ #SkinJointsPodcast #DermatologyInDepth



    Learning Objectives:

    Gain Insight into New Treatments for Alopecia Areata: Learn about the latest advancements and clinical trials discussed at AAD, including newly approved treatments and their application in real world practice.

    Appreciate the Psychosocial Aspects of Dermatological Conditions: Recognize the significant emotional and social challenges faced by patients with alopecia areata and the importance of addressing these in real world practice.

    Implement Clinical Pearls in Practice: Discover actionable tips and strategies that can be immediately applied to improve patient outcomes.

    #SkinAndJointsPodcast #DermatologyDeepDive #SanDiegoSun
    Episode supported by an IME Grant from Pfizer and Bausch Health.


    ABOUT DR. DIANA DIAO FRCPC, FAAD
    Dermatologist  | Vancouver, BC

    Dr. Diana Diao is a Dermatologist and a Clinical Instructor in the Department of Dermatology and Skin Science at the University of British Columbia. She is a consultant dermatologist at both Vancouver General Hospital and St. Paul’s Hospital. Dr. Diao practices medical and procedural dermatology, with a special interest in using energy-based modalities such as lasers to treat a variety of skin conditions.

    Dr. Diao completed both her Medical Doctorate degree and dermatology residency training at the University of British Columbia, and is a Fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Diao is a mother, a published author, and has presented her work at conferences such as the World Congress of Dermatology and the American Academy of Dermatology meetings. Dr. Diao is also fluent in Mandarin.

    • 12 min
    AAD 2024: Late Breakers and New Targets with Dr.Mark Kirchhof

    AAD 2024: Late Breakers and New Targets with Dr.Mark Kirchhof

    🎙️🌞 An AAD 2024 Coles Notes Deep Dive – Welcome to a potpourri episode of the Skin and Joints Podcast, streaming from the vibrant city of San Diego.

    Join us as we sit down with Guest Faculty dermatologist expert the much-anticipated Dr. Mark Kirchhoff, whose voice is as deep and profound as his insights into dermatology. 🎤💬

    Medical Innovations Uncovered:

    • Key Sessions from AAD: We traverse the entire meeting with key insights into significant advancements, focusing on HS, AD, PsO and AA.

    • Late Breaker Highlights: An overview of the most cutting-edge studies presented, including potential new therapies and their implications for future treatment protocols including rethinking long term disease remission to the exploration of new and novel therapeutic targets.



    Learning Objectives:

    Delve into Dermatological Innovations: Get the latest updates on groundbreaking treatments for HS, AA, AD and PsO as well as other skin conditions from the AAD meeting. 🔬💡
    Discuss Future Directions in Dermatology: Examine the potential shifts in treatment approaches and how they align with current patient needs and future therapeutic strategies. 🌟



    Dr. Kirchhoff also reflects on the changing landscape of medical conferences influenced by social media and digital dissemination of knowledge

    Join us for a blend of professional insights and personal anecdotes that promise to educate and entertain. Tune in to catch Dr. Kirchhoff’s voice and vision for the future of dermatology! 📚🎧

    #SkinAndJointsPodcast #DermatologyDeepDive #SanDiegoSun

    Episode supported by an IME Grant from Pfizer and Bausch Health.



    ABOUT DR. MARK KIRCHHOF,MD, PHD, FRCPC, FAAD

    Dermatologist  | Ottawa, ON

    Dr. Mark Kirchhof is the Division Head of Dermatology in the Faculty of Medicine at the University of Ottawa and The Ottawa Hospital. After receiving his Bachelor of Science in molecular biology from McMaster University, Dr. Kirchhof completed his medical degree and PhD at Western University in London, Ontario. His PhD research involved studies of the signalling pathways important to immune system regulation. He then went on to complete his dermatology residency at the University of British Columbia in Vancouver, British Columbia.

    Until August 2017, Dr. Kirchhof was the Education Director at Queen’s University in Kingston, Ontario, where he coordinated and led undergraduate, post-graduate and continuing medical education activities. He has published over 40 peer-reviewed papers and maintains a keen interest in clinical and bench-to-bedside research. He has been invited to speak at local, national and international meetings. His clinical interests are varied and he sees both pediatric and adult patients.

    • 19 min
    LIVE at AAD 2024 San Diego with Dr.Mimi Tran and Dr.Linda Stein Gold: Acne Gamechangers-Clascoterone to Isotretinoin

    LIVE at AAD 2024 San Diego with Dr.Mimi Tran and Dr.Linda Stein Gold: Acne Gamechangers-Clascoterone to Isotretinoin

    🌍✨ Welcome to a US-Canada Acne Dialogue Where we Unpack the Art of Acne Treatment Customization and Master Practical Clinical Pearls.🎙️🍁🇺🇸

    🌉🔬Skin and Joints Podcast Faculty Dermatologist duo, Dr.Linda Stein Gold and Dr. Mimi Tran, converge to unravel a MasterClass on the latest in acne management, distilled straight from the AAD with a focus on defining the role and place of a new topical hormonal anti-androgen agent and why all isotretinoin options are not the same 🌞

    🎯Learning Objectives:

    Advances in Acne Care Innovation: Gain practical insights into the newly released AAD acne guidelines, how they should be used for the patient in front of you, straight from one of the Faculty members that helped create it! Dr.Stein Gold deep dives into the critical balance between guideline recommendations and the nuanced needs of individual patients, highlighting the importance of cost considerations, treatment efficacy, and the patient-practitioner partnership in dermatology.

    Dive into the world of new acne therapies, including the groundbreaking topical androgen receptor blocker and its role in reducing sebum production. A leap forward in topical acne treatment! 🆕💡

    Beyond the Surface: Learn about the significance of vehicle design in topical medications — a crucial factor for efficacy, tolerability, and patient satisfaction. It's not just what's inside that counts, but how it's delivered. 🚚💊

    The Isotretinoin Evolution: Explore the latest advancements in isotretinoin formulations that promise enhanced absorption without the need for fatty meals, paving the way for more effective and flexible treatment options. 🍽️➡️💧

    Empowering Patients: Embrace the power of visual progress tracking with baseline and follow-up photographs, fostering patient engagement and adherence. A picture is worth a thousand words, especially in acne treatment! 📸📈

    🌟 Stay tuned
    #HealthcareCrossroads #AcneInnovation #USCanadaConnection 🎧💬

    EPISODE Supported by SUN Pharma


    ABOUT Dr.Linda F Stein Gold, MD, FAAD
    Dermatologist, Detroit, MI

    Linda Stein Gold, MD, is Director of Dermatology Clinical Research at Henry Ford Health System in Detroit, Michigan, as well as Division Head of Dermatology at Henry Ford Health System in West Bloomfield, Michigan.

    Dr. Stein Gold earned her undergraduate degree at the Wharton School of the University of Pennsylvania and her medical degree from the University Of Pennsylvania School Of Medicine in Philadelphia and completed her residency in dermatology at Henry Ford Hospital in Detroit.

    Dr. Stein Gold is very active in clinical research on a variety of dermatologic conditions, including the treatment of chronic plaque-type psoriasis, actinic keratosis, atopic dermatitis, acne vulgaris, seborrheic dermatitis, and rosacea. She has published articles in journals such as the Journal of the American Academy of Dermatology, Cutis, the Journal of Drugs in Dermatology among others. She is a frequent national and international lecturer on acne, rosacea, psoriasis, actinic keratosis, alopecia, viral infections, atopic dermatitis, and fungal infections, at grand rounds and medical society meetings. She is also the treasurer of the National Acne and Rosacea Society and a member of the National Psoriasis Foundation Medical Board.

    ABOUT Dr. Mimi Tran MD, FRCPC
    Dermatologist, Winnipeg, MB

    Dr Mimi Tran is a dual board-certified Dermatologist in Canada and the USA. After graduating from medical school at the University of Calgary, she pursued a rigorous Dermatology residency at the University of British Columbia. She has trained in centres across Canada. With her extensive experience from practicing in Vancouver, Dr Tran decided to bring her exceptional skills and expertise back to her hometown of Winnipeg. Dr. Tran practices in both Medical and Cosmetic Dermatology. She has a particular interest in Skin Cancer, Acne,

    • 17 min

Top Podcasts In Health & Fitness

Affirmations for Black Girls
Tyra The Creative
On Purpose with Jay Shetty
iHeartPodcasts
Body Stuff with Dr. Jen Gunter
TED
Feel Better, Live More with Dr Rangan Chatterjee
Dr Rangan Chatterjee: GP & Author
The Fat Emperor Podcast
ivor cummins
Huberman Lab
Scicomm Media